Medicinal supply in danger: Minister calls for measures in SH!

Medicinal supply in danger: Minister calls for measures in SH!

Hohenlockstedt, Deutschland - In Hohenlockstedt, an important exchange for security of supply with medicinal products in Schleswig-Holstein took place. Minister of Health Kerstin von der ceilings specified the challenges that affect not only the federal states but also Europe when they received representatives of the North State Association of Pharma Germany and VCI Nord. The minister emphasized the large, multi -layered tasks that must be mastered in the production of drugs. In doing so, she referred to the progress in processing these topics at European level, especially with regard to the strengthening of the supply of critical medicines. This reported News today.

Babette Reiken, chair of the North State Association of Pharma Germany, made it clear how important reliable framework conditions are for the pharmaceutical industry and also called for a secure financing of statutory health insurance (GKV). These aspects are central, because the supply of drugs is not only a challenge for the industry, but also for public health in Germany. A good knack in pricing the basic medication is also crucial, since innovations and the necessary financial foundations were also treated.

challenges of pharmaceutical supply

As part of the exchange, Ilse Boskamp from G. Pohl-Boskamp GmbH called for an adaptation of the drug market reorganization law (AMNOG) in order to ensure the economic adoption and diversity of medicinal products. Your company sees a responsibility for the supply of drugs and emphasized the need to stabilize the legal framework. According to the principle "Prevention is better than healing", digitization also played a central topic. The opportunities in digital health care and the use of health data in Schleswig-Holstein were discussed.

Schleswig-Holstein plays a key role in drug monitoring. The State Office for Social Services monitors the companies that are involved in drug traffic in Schleswig-Holstein. Inspections are carried out that sends samples of medicinal products for examination to the Institute for Pharmaceutical and Applied Analytics (inpha GmbH). The Schleswig-Holstein pharmacist Chamber also has a major role in representing over 3,000 pharmacists and taking on essential tasks to organize emergency pharmacies and planning central emergency deposits as if it were the linchpin for pharmaceutical supply in the country. These aspects are important in order to analyze unwanted side effects of medicinal products and to secure the quality, such as schleswig-holstein.de explains.

drug supply in focus

Medicinal care in Germany is a complex system and at the same time represents the second largest volume of expenditure in statutory health insurance. The constant reform efforts are shown in the legal provisions on pricing, which should control the financial burdens in the healthcare sector. So the focus is not only on quality, but also on the economic compatibility of the pharmaceutical supply. The most recent changes, such as the cancellation of the additional property ban and the approval of the mail order trade, have dynamized the market. But the pressure on the cost damping remains high, since the expenses in the drug sector are increasing steadily, such as bpb.de summarizes.

The talks between the actors from the pharmaceutical industry and politics are a necessary step to master future challenges of pharmaceutical supply. The last meeting in Hohenlockstedt shows how important the dialogue is to find solutions for the multitude of questions that affect both the industry and the patient.